Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STRIDES PHARMA SCIENCE Gains 9%; BSE HEALTHCARE Index Up 0.1%
Thu, 21 Nov 15:21

STRIDES PHARMA SCIENCE Gains 9%; BSE HEALTHCARE Index Up 0.1%Image source: alexsl/www.istockphoto.com

STRIDES PHARMA SCIENCE share price has zoomed 9% and is presently trading at Rs 1,495.7.

Meanwhile, the BSE HEALTHCARE index is at 42,459.7 (up 0.1%).

Among the top gainers in the BSE HEALTHCARE index today are FORTIS HEALTHCARE (up 3.4%) and KIMS (up 3.1%).

SUN PHARMA ADV. RES. (down 3.0%) and GSK Pharma (down 2.7%) are among the top losers today.

Over the last one year, STRIDES PHARMA SCIENCE has moved up from Rs 490.4 to Rs 1,495.7, registering a gain of Rs 1,005.3 (up 205.0%).

On the other hand, the BSE HEALTHCARE index has moved up from 29,583.1 to 42,459.7, registering a gain of 43.5% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 159.9%), SUVEN PHARMACEUTICALS (up 114.6%) and FORTIS HEALTHCARE (up 88.5%).

Don't Miss: Key Information for Long-term Investors

What About the Benchmark Indices?

The BSE Sensex is at 77,172.4 (down 0.5%).

The top losers among the BSE Sensex today are MUNDRA PORT & SEZ (down 13.4%) and NTPC (down 2.8%). The most traded stocks in the BSE Sensex are Tata Steel and MUNDRA PORT & SEZ.

In the meantime, NSE Nifty is at 23,349.4 (down 0.7%). Adani Enterprises and MUNDRA PORT & SEZ are among the top losers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 65,655.2 to 77,172.4, registering a gain of 11,517.3 points (up 17.5%).

STRIDES PHARMA SCIENCE Financial Update...

STRIDES PHARMA SCIENCE net profit grew 199.3% YoY to Rs 1,065 million for the quarter ended September 2024, compared to a loss of Rs 1,072 million a year ago. Net sales rose 20.2% to Rs 12,011 million during the period as against Rs 9,994 million in July-September 2023.

For the year ended March 2024, STRIDES PHARMA SCIENCE reported 35.7% increase in net profit to Rs -1,485 million compared to net loss of Rs 2,309 million during FY23. Revenue of the company grew 9.8% to Rs 40,511 million during FY24.

The current Price to earnings ratio of STRIDES PHARMA SCIENCE, based on rolling 12 month earnings, stands at 46.2.


Equitymaster requests your view! Post a comment on "STRIDES PHARMA SCIENCE Gains 9%; BSE HEALTHCARE Index Up 0.1%". Click here!